Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Erlotinib Hydrochloride × Endocrine × 30 days × Clear all

Sponsor

Cancer Type

Gastrointestinal 3 Thoracic 2 Plasma cell 1 Lymphoid 1 Genitourinary 1

Interventions

Magnetic Resonance Spectroscopy 11 Specimen Handling 10 Everolimus 6 pembrolizumab 4 lutetium Lu 177 dotatate 4 gallium Ga 68 dotatate 4 cabozantinib 4 Nivolumab 4 lenvatinib 3 X-Rays 3 Ipilimumab 3 trametinib 2 pasireotide 2 dabrafenib 2 Temozolomide 2 Phantoms, Imaging 2 Immunoglobulin G 2 Fluorodeoxyglucose F18 2 Etoposide 2 Disulfides 2 Cyclophosphamide 2 Cisplatin 2 CTLA-4 Antigen 2 Bevacizumab 2 tremelimumab 1 spartalizumab 1 relacorilant 1 peposertib 1 pazopanib 1 olaparib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡